Ad
related to: lisinopril warnings precautions for patients
Search results
Results From The WOW.Com Content Network
Lisinopril works by inhibiting the renin–angiotensin–aldosterone system. [7] Lisinopril was patented in 1978 and approved for medical use in the United States in 1987. [7] [11] It is available as a generic medication. [7] In 2022, it was the third most commonly prescribed medication in the United States, with more than 82 million prescriptions.
Lisinopril/hydrochlorothiazide, sold under the brand name Zestoretic among others, is a fixed-dose combination medication used for the treatment of high blood pressure (hypertension). [2] It contains lisinopril , an ACE inhibitor , and hydrochlorothiazide , a diuretic .
Lisinopril/amlodipine, sold under the brand name Lisonorm among others, is a medication used to treat high blood pressure. [1] It is a combination of lisinopril, an ACE inhibitor,with amlodipine, a calcium channel blocker. [1] It may be used when blood pressure is not well controlled with each of the two agents alone. [4] It is taken by mouth. [1]
Patient age, associated clinical conditions and end-organ damage also play a part in determining dosage and type of medication administered. [3] The several classes of antihypertensives differ in side effect profiles, ability to prevent endpoints, and cost.
Auxiliary labels placed on a prescription vial may be placed vertically, horizontally, or on the vial cap, which is called "interactive placement". Placement of the label in an interactive manner where the patient must interact with it to open the vial increases the chance the label is noticed and considered by the patient. [4]
The ACE inhibitor enalapril has also been shown to reduce cardiac cachexia in patients with chronic heart failure. [51] Cachexia is a poor prognostic sign in patients with chronic heart failure. [52] ACE inhibitors are under early investigation for the treatment of frailty and muscle wasting (sarcopenia) in elderly patients without heart ...
Boxed warnings on drugs have received increased media attention in the United States since 2004. Among some of the more widely covered stories: In October 2004, the FDA began requiring that boxed warnings be placed on all antidepressant medications, warning they may result in an increased risk of suicidal tendencies in children and adolescents.
Ultimately, when a drug is marketed it may be used in patient populations that were not studied during clinical trials (children, the elderly, pregnant women, patients with co-morbidities not found in the clinical trial population, etc.) and a different set of warnings, precautions or contraindications (where the drug should not be used at all ...